Recipharm will publish its interim report for January-March 2017 on 27 April at 07:45 am CET.
The company invites investors, analysts and media to a web conference (in English) on 27 April at 09:30 am CET, where CEO and CFO will present and comment on the report as well as answer questions.
The report will be available on Recipharm’s website www.recipharm.com/investor-relations from 07:45 am CET the same day and the presentation from the webcast will be uploaded during the day on the 27 April.
To participate in the web conference, please use the below link: http://edge.media-server.com/m/p/36p8vrr5
Questions may be submitted by dialing below telephone numbers or by typing them in the Q&A box during the conference.
If you don’t wish to ask questions by telephone you only need to participate through the link above. From Sweden: + 46 8 505 963 06
From Denmark: + 45 3 5445 597
From Finland: + 358 9 8171 0317
From Norway: + 47 235 00 559
From the UK: + 44 203 139 48 30
From Germany: +49 30 221 510 067
From Switzerland: +41 44 580 00 83
From France: + 33 29092 0977
From Spain: +34 911 143 608
From Portugal: +35 2 106 091 04
From India: +91 2261 875 103
From Italy: +39 2 3604 67 98
From Israel: +972 3720 86 77
From the USA: +1 718 873 90 77
Pin code for participants:
27643108#
For more information, please contact:
ir@recipharm.com, telephone: +46 8 602 52 00
Recipharm AB (publ)
Corporate identity number 556498-8425
Address Box 603, SE-101 32 Stockholm, Sweden, Telephone +46 8 602 52 00
www.recipharm.com
